Código QR (código de barras bidimensional)

24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review

Abstract Background Buprenorphine (Bup) is a first-line medication for opioid use disorder (OUD) that carries risk of precipitated withdrawal (PW) with ongoing need for rapid and effective initiation strategies. We report a novel approach to low-dose initiation using transdermal Bup patches (TD-Bup)...

ver descrição completa

Na minha lista:
Principais autores: Pouya Azar, Victor W. Li, Mohammadali Nikoo, Jennifer LaBranche, James S. H. Wong, Jessica Machado, Tam To, Alaa Al Hawamdeh, Martha J. Ignaszewski, Andrew A. Herring, Marc Vogel, Laura Kehoe, Amer Raheemullah, Ruchi Fitzgerald, Reinhard M. Krausz, Julio S. G. Montaner, Anil R. Maharaj
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2026-03-01
coleção:Addiction Science & Clinical Practice
Assuntos:
Opioid use disorder
Fentanyl
Buprenorphine
Transdermal
Initiation
Buprenorphine extended-release
Acesso em linha:https://doi.org/10.1186/s13722-026-00657-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados